RF Stock Analysis: Eurazeo | PA
Asset Management | PA, France | Market Cap: 2.661m EUR | 12M Return: -24.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.28M
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Eurazeo SE is a French-listed private equity and venture capital firm operating across multiple investment strategies, including growth capital, leveraged buyouts, buy-ins, and minority investments in listed public companies. It targets medium-sized and large companies, SMEs, and high-growth businesses, with no strict sector restrictions but a clear preference for areas such as smart cities, fintech, real estate, luxury, consumer brands, healthcare, digital health, and tech. The firm focuses on companies with differentiated concepts and global growth potential, particularly those benefiting from digital transformation and shifting consumer behaviors (e.g., mobility, online commerce, and new collaboration models).
Geographically, Eurazeo invests primarily in the United States and Western Europe, with a notable presence in New York, Paris, Italy, North America, and other European countries, and some exposure to China. According to the provided description, it typically invests between €50 million and €250 million in small-mid buyout transactions, €25 million to €100 million in growth-stage deals, and lower ticket sizes in earlier-stage ventures. The firm also engages in real estate activities, including the restructuring of large properties and residential, commercial, and office development projects in Western Europe.
As a publicly listed investment company in the asset management sub-industry, Eurazeo raises capital from public markets and limited partners to deploy across its funds, generating returns through capital appreciation, dividends, and exits via trade sales or IPOs, a structure typical of listed alternative asset managers.
- Private equity exits accelerate boosting performance fees
- European rate cuts revive deal activity and valuations
- Real estate segment NAV pressured by elevated interest rates
| Net Income: -403.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.98 > 1.0 |
| NWC/Revenue: -147.5% < 20% (prev -384.3%; Δ 236.9% < -1%) |
| CFO/TA 0.01 > 3% & CFO 88.8m > Net Income -403.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.8m) vs 12m ago -28.33% < -2% |
| Gross Margin: 68.73% > 18% (prev 64.54%; Δ 4.19% > 0.5%) |
| Asset Turnover: 4.86% > 50% (prev 3.18%; Δ 1.68% > 0%) |
| Interest Coverage Ratio: -5.01 > 6 (EBIT TTM -353.4m / Interest Expense TTM 70.5m) |
| A: -0.08 (Total Current Assets 351.3m - Total Current Liabilities 982.1m) / Total Assets 8.19b |
| B: 0.74 (Retained Earnings 6.08b / Total Assets 8.19b) |
| C: -0.04 (EBIT TTM -353.4m / Avg Total Assets 8.80b) |
| D: 3.68 (Book Value of Equity 6.25b / Total Liabilities 1.70b) |
| Altman-Z'' = 5.52 = AAA |
| DSRI: 0.53 (Receivables 191.6m/253.3m, Revenue 427.8m/299.7m) |
| GMI: 0.94 (GM 64.54% / 68.73%) |
| AQI: 1.00 (AQ_t 0.95 / AQ_t-1 0.95) |
| SGI: 1.43 (Revenue 427.8m / 299.7m) |
| TATA: -0.06 (NI -403.5m - CFO 88.8m) / TA 8.19b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at EUR 41.64 with a total of 75,586 shares traded. Over the past week, the price has changed by +4.10%, over one month by -4.06%, over three months by +7.39% and over the past year by -24.05%.
Current recommended Stop Loss: 40.20 (which is 3.5% or 1.4 ATR below the current price).
Eurazeo has no consensus analysts rating.
P/E Forward = 15.4321
P/S = 62.304
P/B = 0.418
P/EG = 0.0293
Revenue TTM = 427.8m EUR
EBIT TTM = -353.4m EUR
EBITDA TTM = -337.0m EUR
Long Term Debt = 199.3m EUR (from longTermDebt, last quarter)
Short Term Debt = 982.1m EUR (from shortTermDebt, last quarter)
Debt = 1.33b EUR (from shortLongTermDebtTotal, last quarter) + Leases 79.6m
Net Debt = 1.22b EUR (calculated: Debt 1.33b - CCE 114.8m)
Enterprise Value = 3.88b EUR (2.66b + Debt 1.33b - CCE 114.8m)
Interest Coverage Ratio = -5.01 (Ebit TTM -353.4m / Interest Expense TTM 70.5m)
EV/FCF = 44.67x (Enterprise Value 3.88b / FCF TTM 86.8m)
FCF Yield = 2.24% (FCF TTM 86.8m / Enterprise Value 3.88b)
FCF Margin = 20.29% (FCF TTM 86.8m / Revenue TTM 427.8m)
Net Margin = -94.33% (Net Income TTM -403.5m / Revenue TTM 427.8m)
Gross Margin = 68.73% ((Revenue TTM 427.8m - Cost of Revenue TTM 133.8m) / Revenue TTM)
Gross Margin QoQ = 82.70% (prev none%)
Tobins Q-Ratio = 0.47 (Enterprise Value 3.88b / Total Assets 8.19b)
Interest Expense / Debt = 5.30% (Interest Expense 70.5m / Debt 1.33b)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = -265.0m (EBIT -353.4m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 0.36 (Total Current Assets 351.3m / Total Current Liabilities 982.1m)
Debt / Equity = 0.21 (Debt 1.33b / totalStockholderEquity, last quarter 6.25b)
Debt / EBITDA = -3.61 (negative EBITDA) (Net Debt 1.22b / EBITDA -337.0m)
Debt / FCF = 14.01 (Net Debt 1.22b / FCF TTM 86.8m)
Total Stockholder Equity = 6.95b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.58% (Net Income -403.5m / Total Assets 8.19b)
RoE = -5.80% (Net Income TTM -403.5m / Total Stockholder Equity 6.95b)
RoCE = -4.94% (EBIT -353.4m / Capital Employed (Equity 6.95b + L.T.Debt 199.3m))
RoIC = -3.25% (negative operating profit) (NOPAT -265.0m / Invested Capital 8.17b)
WACC = 7.62% (E(2.66b)/V(3.99b) * Re(9.45%) + D(1.33b)/V(3.99b) * Rd(5.30%) * (1-Tc(0.25)))
Discount Rate = 9.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -46.67 | Cagr: -13.10%
[DCF] Terminal Value 77.97% ; FCFF base≈55.1m ; Y1≈63.2m ; Y5≈93.0m
[DCF] Fair Price = 2.87 (EV 1.40b - Net Debt 1.22b = Equity 183.3m / Shares 63.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -81.15 | Revenue CAGR: -71.76% | SUE: 0.00 | # QB: 0
EPS current Year (2026-12-31): EPS=2.64 | Chg30d=-33.51% | Revisions=-25% | GrowthEPS=+147.5% | GrowthRev=+8.1%
EPS next Year (2027-12-31): EPS=8.73 | Chg30d=-13.14% | Revisions=-40% | GrowthEPS=+231.3% | GrowthRev=+9.2%
[Analyst] Revisions Ratio: -50% (up=0, down=3)